Background: The European AIDS Clinical Society (EACS) guidelines are intended for all clinicians involved in the care of HIV-positive persons, and are available in print, online, and as a free App for download for iPhone and Android. Guideline highlights: The 2015 version of the EACS guidelines contains major revisions in all sections; antiretroviral treatment (ART), comorbidities, coinfections and opportunistic diseases. Among the key revisions is the recommendation of ART for all HIV-positive persons, irrespectively of CD4 count, based on the Strategic Timing of AntiRetroviral Treatment (START) study results. The recommendations for the preferred and the alternative ART options have also been revised, and a new section on the use of pre-e...
Antiretroviral therapy (ART) for the treatment of HIV infection has improved steadily since the adve...
Context: New trial data and drug regimens that have become available in the last 2 years warrant an ...
Context: The availability of new antiretroviral drugs and formulations, including drugs in new class...
Background: The European AIDS Clinical Society (EACS) guidelines are intended for all clinicians inv...
BACKGROUND The European AIDS Clinical Society (EACS) guidelines are intended for all clinicians i...
The European AIDS Clinical Society (EACS) Guidelines have since 2005 provided multidisciplinary reco...
International audienceBackground: The European AIDS Clinical Society (EACS) Guidelines have since 20...
BACKGROUND: The European AIDS Clinical Society (EACS) Guidelines have since 2005 provided multidisci...
BACKGROUND: The European AIDS Clinical Society (EACS) Guidelines were revised in 2021 for the 17th t...
Background The European AIDS Clinical Society (EACS) Guidelines cover key aspects of HIV management ...
The European AIDS Clinical Society (EACS) Guidelines cover key aspects of HIV management with major ...
A working group of the European AIDS Clinical Society (EACS) have developed these guidelines for Eur...
BACKGROUND The European AIDS Clinical Society (EACS) Guidelines were revised in 2021 for the 17th...
OBJECTIVES: With the decline in HIV-associated morbidity and mortality following the introduction of...
The guidelines for treatment of patients with HIV infection developed in the United States (DHHS) an...
Antiretroviral therapy (ART) for the treatment of HIV infection has improved steadily since the adve...
Context: New trial data and drug regimens that have become available in the last 2 years warrant an ...
Context: The availability of new antiretroviral drugs and formulations, including drugs in new class...
Background: The European AIDS Clinical Society (EACS) guidelines are intended for all clinicians inv...
BACKGROUND The European AIDS Clinical Society (EACS) guidelines are intended for all clinicians i...
The European AIDS Clinical Society (EACS) Guidelines have since 2005 provided multidisciplinary reco...
International audienceBackground: The European AIDS Clinical Society (EACS) Guidelines have since 20...
BACKGROUND: The European AIDS Clinical Society (EACS) Guidelines have since 2005 provided multidisci...
BACKGROUND: The European AIDS Clinical Society (EACS) Guidelines were revised in 2021 for the 17th t...
Background The European AIDS Clinical Society (EACS) Guidelines cover key aspects of HIV management ...
The European AIDS Clinical Society (EACS) Guidelines cover key aspects of HIV management with major ...
A working group of the European AIDS Clinical Society (EACS) have developed these guidelines for Eur...
BACKGROUND The European AIDS Clinical Society (EACS) Guidelines were revised in 2021 for the 17th...
OBJECTIVES: With the decline in HIV-associated morbidity and mortality following the introduction of...
The guidelines for treatment of patients with HIV infection developed in the United States (DHHS) an...
Antiretroviral therapy (ART) for the treatment of HIV infection has improved steadily since the adve...
Context: New trial data and drug regimens that have become available in the last 2 years warrant an ...
Context: The availability of new antiretroviral drugs and formulations, including drugs in new class...